Alan Kastner, None;
Giovanni Montesano, CenterVue (C);
C Gustavo De Moraes, Belite (C), Carl Zeiss (C), Galimedix (C), Heidelberg (R), NIH (R), Novartis (C), Perfuse Therapeutics (C), Reichart (C), Research to Prevent Blindness (R), Topcon (R);
Jae Kang, None;
Janey Wiggs, Aerpio (F), Allergan (C), Editas (C), Maze (C), Regenxbio (C);
Louis Pasquale, Bausch+Lomb (C), Emerald Bioscience (C), Eyenovia (C), Nicox (C), Verily (C);
Pirro Hysi, None;
Sharon Chua, None;
Praveen Patel, None;
Paul Foster, 90Ten (C), AlphaSights (C), DeepMind/Google (C), GLG (C), InHouse Research (C), Simon Kucher (C);
Sir Peng Khaw, Aerie Pharmaceuticals (C), Alcon (C), Belkin (C), Glaukos (C), GLG (C), ISARNA (C), Muller Cells (P), Novartis (C), Radiance (I), Radiance Tx (C), Santen Pharmaceuticals (C), Thea Pharmaceuticals (C), Valid Insight (C);
Anthony Khawaja, Aerie (C), Allergan (C), Google (C), Novartis (C), Santen (C)